Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

VG Life Sciences Inc. (VGLS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0005-0.0001 (-16.67%)
At close: 03:55PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/13/2021
Current
Market Cap (intraday)
1.08M
Enterprise Value
4.44M
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
32.38
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
-1.96

Trading Information

Stock Price History

Beta (5Y Monthly) 0.36
52-Week Change 3-90.91%
S&P500 52-Week Change 318.79%
52 Week High 30.0190
52 Week Low 30.0004
50-Day Moving Average 30.0015
200-Day Moving Average 30.0038

Share Statistics

Avg Vol (3 month) 370.24M
Avg Vol (10 day) 3205.54M
Shares Outstanding 5107.88M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2014
Most Recent Quarter (mrq)Sep 29, 2015

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-151.18%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-4.3M
Diluted EPS (ttm)-0.0710
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.92k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.38M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.01
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-858.34k
Levered Free Cash Flow (ttm)-1.46M
Advertisement
Advertisement